WNV-HCD86

N/A

Report date: 2023/10/31 14:52:13

Base Information

Drug NameWNV-HCD86
Drug Alias NameWNV-HCD86DS1-H2-1
ClassificationBiologics > Oncolytic virusCell and gene therapy > Gene therapy
Mechanisms of ActionCluster of differentiation 86 modulators
TargetsCluster of differentiation 86
Therapy Area/IndicationsSmall Cell Lung CarcinomaLiver NeoplasmsNeuroblastoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesSichuan Ankekang Biological Medicine Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSichuan Ankekang Biological Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaLiver NeoplasmsNeuroblastoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A